RVMDW
Revolution Medicines, Inc. Warrant
NASDAQ · Healthcare · Biotechnology · US
$11.89
−0.79%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+115.8%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Feb 10, 2026 | GOLDSMITH MARK A · director, officer: See Remarks | M-Exempt | 24,010 | $0.54 |
| Jan 23, 2026 | Cislini Jeff · officer: General Counsel | Sale | 908 | $116 |
| Jan 9, 2026 | Horn Margaret A · officer: Chief Operating Officer | Sale | 53,096 | $100 |
| Jan 9, 2026 | Horn Margaret A · officer: Chief Operating Officer | M-Exempt | 23,594 | $30 |
| Jan 9, 2026 | Horn Margaret A · officer: Chief Operating Officer | M-Exempt | 51,406 | $42 |
| Jan 9, 2026 | Anders Jack · officer: Chief Financial Officer | Sale | 10,000 | $98 |
| Jan 9, 2026 | Horn Margaret A · officer: Chief Operating Officer | Sale | 20,204 | $102 |
| Jan 9, 2026 | Anders Jack · officer: Chief Financial Officer | M-Exempt | 10,000 | $42 |
| Jan 9, 2026 | Horn Margaret A · officer: Chief Operating Officer | Sale | 1,700 | $103 |
| Dec 18, 2025 | Anders Jack · officer: Chief Financial Officer | Sale | 3,104 | $77 |
| Dec 18, 2025 | Cislini Jeff · officer: General Counsel | Sale | 2,688 | $77 |
| Dec 18, 2025 | Kelsey Stephen Michael · officer: See Remarks | Sale | 5,447 | $77 |
| Dec 18, 2025 | GOLDSMITH MARK A · director, officer: See Remarks | Sale | 15,394 | $77 |
| Dec 18, 2025 | Horn Margaret A · officer: Chief Operating Officer | Sale | 4,847 | $77 |
| Nov 26, 2025 | Anders Jack · officer: Chief Financial Officer | M-Exempt | 5,418 | $17 |
| Nov 26, 2025 | GOLDSMITH MARK A · director, officer: See Remarks | Sale | 3,000 | $75 |
| Nov 26, 2025 | GOLDSMITH MARK A · director, officer: See Remarks | M-Exempt | 60,000 | $4.09 |
| Nov 26, 2025 | GOLDSMITH MARK A · director, officer: See Remarks | Sale | 60,000 | $75 |
| Nov 26, 2025 | Anders Jack · officer: Chief Financial Officer | Sale | 5,418 | $74 |
| Nov 20, 2025 | Cislini Jeff · officer: General Counsel | Sale | 13,388 | $70 |
| Nov 20, 2025 | GOLDSMITH MARK A · director, officer: See Remarks | Sale | 20,000 | $70 |
| Nov 20, 2025 | Cislini Jeff · officer: General Counsel | M-Exempt | 13,388 | $42 |
| Nov 20, 2025 | GOLDSMITH MARK A · director, officer: See Remarks | M-Exempt | 20,000 | $4.09 |
| Nov 14, 2025 | GOLDSMITH MARK A · director, officer: See Remarks | Sale | 20,000 | $65 |
| Nov 14, 2025 | GOLDSMITH MARK A · director, officer: See Remarks | M-Exempt | 20,000 | $4.09 |
| Nov 13, 2025 | Anders Jack · officer: Chief Financial Officer | Sale | 10,000 | $64 |
| Nov 13, 2025 | Anders Jack · officer: Chief Financial Officer | M-Exempt | 10,000 | $17 |
| Nov 12, 2025 | GOLDSMITH MARK A · director, officer: See Remarks | M-Exempt | 26,479 | $1.12 |
| Nov 12, 2025 | GOLDSMITH MARK A · director, officer: See Remarks | Sale | 30,000 | $60 |
| Nov 12, 2025 | GOLDSMITH MARK A · director, officer: See Remarks | M-Exempt | 3,521 | $4.09 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Feb 10, 2026